Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study

Blood (2019) 134 (Supplement_1): 754.

https://doi.org/10.1182/blood-2019-126064

Published: 2019

Journal Articles

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Maria Stamouli, Ioannis Tsonis, MD, Konstantinos Gkirkas, Christina Economopoulou, Thomas Thomopoulos, MD, Anna Paisiou, MD, Nikolaos Siafakas, Spyridon Pournaras, Anastasia Antoniadou, Aggeliki Karagiannidi, Joseph Meletiadis, Dimitra Kavatha, George Vassilopoulos, MD PhD, Stavros Gigantes, MD, Ioannis Baltadakis, MD, Evgenios Goussetis, Dimitrios Karakasis, MD, Panagiotis Tsirigotis

Blood (2019) 134 (Supplement_1): 4498.

https://doi.org/10.1182/blood-2019-128362

Published: 2019

Journal Articles

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Mehrdad Hefazi, MD, Reona Sakemura, MD PhD, Saad S. Kenderian, MD, Mrinal M Patnaik, MDMBBS, William J Hogan, MB, BCh, Mark Litzow, MD, Hemang Yadav, MBBS

Blood (2019) 134 (Supplement_1): 4500.

https://doi.org/10.1182/blood-2019-132133

Published: 2019

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 682.

https://doi.org/10.1182/blood-2018-99-117848

Published: 2018

Journal Articles

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

Kevin C. Miller, BS, Aref Al-Kali, MD, William J. Hogan, MBBCh, Michelle A. Elliott, MD, Kebede H. Begna, MD, Naseema Gangat, MBBS, Mrinal M. Patnaik, MDMBBS, Lisa Sproat, MD MSW, James M. Foran, MD, Mark R. Litzow, MD, Hassan B. Alkhateeb, MD

Blood (2017) 130 (Supplement 1): 5010.

https://doi.org/10.1182/blood.V130.Suppl_1.5010.5010

Published: 2017

Journal Articles

A Novel Mutation Causing GATA2 Haploinsufficiency Activates a Cryptic Splice Site in Exon 3

Claudia Wehr, Katja Grotius, Dorothee Bleckmann, Emilia J Kozyra, Sebastian Bode, Björn C Frye, Marcin W. Wlodarski, MD PhD, Maximilian Seidl, Ulrich Salzer

Blood (2017) 130 (Supplement 1): 2467.

https://doi.org/10.1182/blood.V130.Suppl_1.2467.2467

Published: 2017

Journal Articles

Long-Term Follow-up of Patients with Chronic Granulomatous Disease Receiving Bone Marrow Transplantation Using Immunosuppressive Conditioning Regimen

Masao Kobayashi, MD PhD, Yoko Mizoguchi, MD, Shuhei Karakawa, MD, Mizuka Miki, MD, Shiho Nishimura, MD, Satoshi Okada, MD, Hiroshi Kawaguchi, MD

Blood (2017) 130 (Supplement 1): 3574.

https://doi.org/10.1182/blood.V130.Suppl_1.3574.3574

Published: 2017

Journal Articles

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Nakul Singhal, MD, Rashi Sharma, MD, Ashwin Chandar, MD, Vincent McAuliffe, MD, Dennis L Cooper, MD

Blood (2016) 128 (22): 2412.

https://doi.org/10.1182/blood.V128.22.2412.2412

Published: 2016

Journal Articles

Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor, Pinometostat, EPZ-5676, in Children with Relapsed or Refractory MLL-r Acute Leukemia: Safety, Exposure and Target Inhibition

Neerav Shukla, MD, Maureen M. O'Brien, MD, Lewis B. Silverman, MD, Melinda Pauly, MD, Cynthia Wetmore, MD PhD, Mignon L. Loh, MD, James A. Whitlock, MD, Patrick Brown, MD, Blythe Thomson, MD, Stephen J. Blakemore, PhD, Scott Daigle, Patricia Pimentel, Nigel J. Waters, PhD, Andrei V Krivstov, PhD, Richard Koche, PhD, Scott A. Armstrong, MD PhD, Peter T Ho, PhD MD, Lia Gore, MD

Blood (2015) 126 (23): 3792.

https://doi.org/10.1182/blood.V126.23.3792.3792

Published: 2015

Journal Articles

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Thompson A Philip, MBBS, FRACP, FRCPA, Andrew B M Lim, MBBS, FRACP, FRCPA, Mark Tacey, Ramzi Hijazi, MBBS, Ashley P. Ng, MBBS, BMedSc, PhD, FRACP, FRCPA, Jeffrey Szer, BMedSc, MBBS, FRACP, David Ritchie, MBBS, PhD, FRACP, FRCPA, Ashish R. Bajel, MBBS, FRACP, FRCPA

Blood (2013) 122 (21): 4603.

https://doi.org/10.1182/blood.V122.21.4603.4603

Published: 2013

Journal Articles

Pulmonary Clinicopathological Correlation In Long Term Survivors Following Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series

Laura Spring, MD, Lee Gazourian, MD, Lynette Sholl, MD, Jyothi Jagannathan, MD, Emily Meserve, MD, Ami S. Bhatt, MD, PhD, Gerald L. Weinhouse, MD, Victor Pinto-Plata, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Vincent T. Ho, MD, Rebecca M. Baron, MD, George R. Washko, MD

Blood (2013) 122 (21): 2070.

https://doi.org/10.1182/blood.V122.21.2070.2070

Published: 2013

Journal Articles

Non Malignant Late Complications After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT); Korean Experience

Silvia Park, Su Jin Lee, Won jin Chang, Chi Hoon Maeng, Jung Yong Hong, Moon Ki Choi, Sung Hee Lim, Ji Yun Lee, Chul Won Jung, Jun Ho Jang, MD, PhD, Kihyun Kim, Young Saing Kim, Je-Hwan Lee, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2012) 120 (21): 4462.

https://doi.org/10.1182/blood.V120.21.4462.4462

Published: 2012

Journal Articles

A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia

Magdalena M. Gorska, Rafeul Alam

Blood (2012) 119 (6): 1399–1406.

https://doi.org/10.1182/blood-2011-04-350686

Published: 2012

Includes: Supplemental data

Journal Articles

Severe Pulmonary Complication in Chemotherapy-Naive African-American Patient Following Bortezomib Therapy: a Case Report

Elizabeth G Befekadu, M.D, Khadega A Abuelgasim, MD, Anita Aggarwal, DO, PhD

Blood (2011) 118 (21): 5144.

https://doi.org/10.1182/blood.V118.21.5144.5144

Published: 2011

Journal Articles

Romiplostim (AMG531, Nplate ® ) for Secondary Failure of Platelet Recovery After Allogeneic Stem-Cell Transplantation

Claire Calmettes, Stephane Vigouroux, Reza Tabrizi, MD, Noel Milpied, MD

Blood (2011) 118 (21): 1994.

https://doi.org/10.1182/blood.V118.21.1994.1994

Published: 2011

Journal Articles

Retransplantation From Haploidentical Donors After Graft Failure in Pediatric Patients Results in Low Transplant Related Mortality and Favourable Long Term Survival

Heiko-Manuel M Teltschik, MD, Frank Heinzelmann, MD, Tobias F. Feuchtinger, MD, Matthias Pfeiffer, MD, Ingo Müller, MD, Rupert Handgretinger, MD, Peter Lang, MD

Blood (2011) 118 (21): 1956.

https://doi.org/10.1182/blood.V118.21.1956.1956

Published: 2011

Journal Articles

Tolerability of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Andrew Manson, Reem Karmali, MD, Irene Dehghan-Paz, MD, Eduardo Braun, MD, Teresa O'Brien, Stephanie A. Gregory, MD, Jamile M. Shammo, MD, Melissa L Larson, MD, Parmeswaran Venugopal, MD

Blood (2010) 116 (21): 4918.

https://doi.org/10.1182/blood.V116.21.4918.4918

Published: 2010

Journal Articles

Phase II Study of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Reem Karmali, MD, Andrew Manson, Katherine Bueschel, MD, Kathryn Shell, Stephanie A. Gregory, MD, Teresa O'Brien, Jamile M. Shammo, MD, Melissa L Larson, MD, Parmeswaran Venugopal, MD

Blood (2010) 116 (21): 3947.

https://doi.org/10.1182/blood.V116.21.3947.3947

Published: 2010

Journal Articles

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

M. Mansour Ceesay, MRCP, FRCPath, Ouni Jaffer, Phillip FC Lung, Michael T Marrinan, Ranjit Deshpande, Nicola Mullholland, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, DM, FRCP, FRCPath, Sujal R Desai, MBBS, MD, FRCR

Blood (2010) 116 (21): 4551.

https://doi.org/10.1182/blood.V116.21.4551.4551

Published: 2010

NARROW

KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

A Novel Mutation Causing GATA2 Haploinsufficiency Activates a Cryptic Splice Site in Exon 3

Long-Term Follow-up of Patients with Chronic Granulomatous Disease Receiving Bone Marrow Transplantation Using Immunosuppressive Conditioning Regimen

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor, Pinometostat, EPZ-5676, in Children with Relapsed or Refractory MLL-r Acute Leukemia: Safety, Exposure and Target Inhibition

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Pulmonary Clinicopathological Correlation In Long Term Survivors Following Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series

Non Malignant Late Complications After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT); Korean Experience

A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia

Severe Pulmonary Complication in Chemotherapy-Naive African-American Patient Following Bortezomib Therapy: a Case Report

Romiplostim (AMG531, Nplate ® ) for Secondary Failure of Platelet Recovery After Allogeneic Stem-Cell Transplantation

Retransplantation From Haploidentical Donors After Graft Failure in Pediatric Patients Results in Low Transplant Related Mortality and Favourable Long Term Survival

Tolerability of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Phase II Study of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only